~11 spots leftby May 2025

Nerve Blocks for Knee Replacement Surgery

Recruiting in Palo Alto (17 mi)
JL
Overseen byJiabin Liu, MD, PhD
Age: 18+
Sex: Any
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Phase 4
Recruiting
Sponsor: Hospital for Special Surgery, New York
Must not be taking: Anticonvulsants
Disqualifiers: Chronic pain, Chronic opioid use, Neuropathy, others
No Placebo Group
Prior Safety Data
Approved in 2 Jurisdictions

Trial Summary

What is the purpose of this trial?

This trial is testing if adding two specific nerve blocks to the usual pain management can better control pain and reduce the need for opioids in patients having knee replacement surgery. The study aims to see if this approach helps with pain relief and quicker recovery.

Will I have to stop taking my current medications?

The trial does not specify if you need to stop taking your current medications, but if you are currently taking anticonvulsants, you cannot participate in the trial.

What data supports the effectiveness of the treatment Genicular and Anterior Femoral Cutaneous Nerve Blocks for knee replacement surgery?

Research shows that genicular nerve blocks can provide effective pain relief and improve function in patients with knee osteoarthritis, and they have been found to reduce opioid use after knee replacement surgery. Additionally, femoral nerve blocks have been shown to significantly reduce the need for pain medication after knee surgery.12345

Is the genicular nerve block safe for humans?

Genicular nerve blocks have been used safely in various settings, such as for acute knee pain in the emergency department, where they provided effective pain relief without the need for opioids. They are considered a safe option for pain management with easily identifiable targets using ultrasound.12678

How is the treatment of Genicular and Anterior Femoral Cutaneous Nerve Blocks for knee replacement surgery different from other treatments?

This treatment is unique because it targets specific nerves (genicular and anterior femoral cutaneous) to manage pain after knee replacement surgery, potentially offering a more focused approach compared to traditional methods like femoral nerve blocks or periarticular infiltration, which may involve broader nerve coverage.1391011

Research Team

JL

Jiabin Liu, MD, PhD

Principal Investigator

Hospital for Special Surgery, New York

Eligibility Criteria

This trial is for adults aged 18-80 undergoing knee replacement surgery without chronic opioid use, severe kidney disease, allergies to local anesthetics or study drugs, neurological deficits, or certain other health issues. They must have a BMI under 35 and not be on anticonvulsants.

Inclusion Criteria

BMI < 35
ASA I-III
I am between 18 and 80 years old.
See 1 more

Exclusion Criteria

Psychiatric or cognitive disorder that prohibits patient from following study protocol
I cannot have spinal or epidural anesthesia.
I have a long-term pain condition.
See 9 more

Trial Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants undergo total knee arthroplasty with either standard care or additional genicular and anterior femoral cutaneous nerve blocks

1 day
1 visit (in-person)

Immediate Post-operative Care

Participants are monitored in the post-anesthesia care unit (PACU) for pain management and readiness for discharge

24 hours
Continuous monitoring

Follow-up

Participants are monitored for pain levels and opioid consumption post-surgery

7 days
Daily assessments

Treatment Details

Interventions

  • Genicular and Anterior Femoral Cutaneous Nerve Blocks (Procedure)
Trial OverviewThe study tests if adding genicular and anterior femoral cutaneous nerve blocks to standard care reduces pain and opioid use after knee surgery. Participants are randomly assigned to receive these nerve blocks or not as part of their post-surgery care.
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: Group 2 Genicular TKAExperimental Treatment4 Interventions
The genicular group will receive the study intervention of a genicular nerve block and anterior femoral cutaneous nerve block. The intervention group (genicular nerve block/anterior femoral cutaneous nerve block) will receive additional nerve blocks totaling 30 ml of 0.25% bupivacaine with 4 mg preservative-free dexamethasone (5 ml for each block: SMGN, IMGN, SLGN, NVI; 10ml for AFCN). The genicular group will be given 2-5 mg of intravenous midazolam and up to 100 mcg fentanyl for sedation and analgesia while the peripheral nerve blocks and spinal anesthesia are being performed. All patients will receive a spinal anesthetic (1.5% mepivacaine 52.5 - 60mg) and the standard adductor canal block and infiltration between the popliteal artery and posterior knee capsule block (20 ml of 0.25% bupivacaine with 2 mg preservative free dexamethasone for each block).
Group II: Group 1 Standard TKAActive Control1 Intervention
The standard TKA group will receive the standard of care analgesia. Those in the control group will be given 7 mg of the preservative dexamethasone intravenously. The standard group will be given 2-5 mg of intravenous midazolam and up to 100 mcg fentanyl for sedation and analgesia while the peripheral nerve blocks and spinal anesthesia are being performed. All patients will receive a spinal anesthetic (1.5% mepivacaine 52.5 - 60mg) as well as the standard adductor canal block and infiltration between the popliteal artery and posterior knee capsule block (20 ml of 0.25% bupivacaine with 2 mg preservative free dexamethasone for each block).

Find a Clinic Near You

Who Is Running the Clinical Trial?

Hospital for Special Surgery, New York

Lead Sponsor

Trials
257
Recruited
61,800+
Dr. Douglas E. Padgett profile image

Dr. Douglas E. Padgett

Hospital for Special Surgery, New York

Chief Medical Officer since 2023

MD from Cornell University Medical College

Dr. Bryan T. Kelly profile image

Dr. Bryan T. Kelly

Hospital for Special Surgery, New York

Chief Executive Officer since 2023

MD, MBA

Findings from Research

In a study of 140 patients undergoing total knee arthroplasty, intraoperative landmark-based genicular nerve blocks (GNB) provided similar resting pain relief compared to periarticular infiltration (PAI), with both groups reporting median pain scores of 0 at 12 hours post-surgery.
However, GNB did not achieve non-inferiority for pain during movement, as patients in the GNB group experienced higher pain scores and required more intravenous morphine for pain management compared to the PAI group.
Intraoperative landmark-based genicular nerve block versus periarticular infiltration for postoperative analgesia in total knee arthroplasty: a randomized non-inferiority trial.Kertkiatkachorn, W., Ngarmukos, S., Tanavalee, A., et al.[2023]
In a study of 26 patients with knee osteoarthritis in Cameroon, genicular nerve blockade significantly reduced pain and perceived difficulty, indicating its efficacy as a treatment option.
The procedure also improved gait and stair climbing performance, with notable increases in cadence and joint motion, demonstrating immediate functional benefits for patients.
Lower limb kinematics improvement after genicular nerve blockade in patients with knee osteoarthritis: a milestone study using inertial sensors.Lebleu, J., Fonkoue, L., Bandolo, E., et al.[2022]
Administering a femoral nerve block with Bupivacaine 0.5% before knee joint reconstruction surgery significantly reduced the need for opiate pain relief by 80% in the recovery room and 40% in the first 24 hours post-surgery.
The study highlights that performing a femoral nerve block is an effective and quick technique that can greatly enhance postoperative pain management for patients undergoing anterior cruciate ligament reconstruction.
Femoral nerve block in knee joint surgery.Ringrose, NH., Cross, MJ.[2017]

References

Intraoperative landmark-based genicular nerve block versus periarticular infiltration for postoperative analgesia in total knee arthroplasty: a randomized non-inferiority trial. [2023]
Lower limb kinematics improvement after genicular nerve blockade in patients with knee osteoarthritis: a milestone study using inertial sensors. [2022]
Femoral nerve block in knee joint surgery. [2017]
Ultrasound-guided genicular nerve blocks following total knee arthroplasty: a randomized, double-blind, placebo-controlled trial. [2022]
Procedural Approach to Ultrasound-Guided Geniculate Nerve Blockade for Knee Pain in Patients with OA. [2023]
Accuracy of Ultrasound-Guided Genicular Nerve Block: A Cadaveric Study. [2022]
Novel Use of 3-Point Genicular Nerve Block for Acute Knee Pain in the Emergency Department. [2021]
Accuracy of fluoroscopic-guided genicular nerve blockade: a need for revisiting anatomical landmarks. [2021]
Femoral versus Multiple Nerve Blocks for Analgesia after Total Knee Arthroplasty. [2020]
[Postoperative analgesia in knee arthroplasty using an anterior sciatic nerve block and a femoral nerve block]. [2019]
11.United Statespubmed.ncbi.nlm.nih.gov
Continuous femoral nerve block versus intra-articular injection for pain control after anterior cruciate ligament reconstruction. [2022]